肌张力障碍的单基因变异:一项全外显子组测序研究
该研究对764例肌张力障碍患者及346名健康父母进行全外显子组测序,在728个家庭中135个(19%)检出致病或可能致病变异,涉及78种单基因病。伴其他神经系统症状者诊断率(45%)高于合并型(19%)和孤立型(4%),并发现11个新关联基因及IMPDH2候选基因。
要点
- 肌张力障碍患者中19%可检出单基因致病变异,涉及78种疾病。
- 伴非运动症状者诊断率最高(45%),孤立型最低(4%)。
- 65%的变异累及神经发育相关基因,提示广泛遗传异质性。
核心结论
- 全外显子组测序在19%的肌张力障碍家庭中检出致病或可能致病变异。
- 伴其他神经系统症状者遗传诊断率显著高于孤立型或合并型。
研究设计与样本
- 研究纳入来自7国33个中心的764例肌张力障碍患者及346名健康父母。
- 对参与者血液DNA进行全外显子组测序,按ACMG指南过滤和分类变异。
主要发现
- 728个家庭中135个(19%)检出致病或可能致病变异,涉及78种单基因病。
- 伴非运动症状者诊断率45%(100/222),合并型19%(19/98),孤立型4%(16/388)。
- 160个检出变异中104个(65%)累及神经发育障碍相关基因。
- 发现11个既往未与肌张力障碍关联的基因存在诊断性变异。
- 在15个家庭中界定12个候选基因,包括IMPDH2的6个预测有害新生变异。
关键数值与推荐
- 诊断性变异定义为通过过滤和解读流程的变异。
- 未报道变异按ACMG指南分类,并经专家圆桌会议审核临床意义。
临床怎么用
- 对肌张力障碍患者,尤其伴其他神经系统症状者,可考虑全外显子组测序。
- 研究提出的预测性临床评分可能指导常规诊断中全外显子组测序的实施。
- 无围产期哨兵事件者,基因组改变对肌张力障碍性脑瘫诊断有实质贡献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dystonia is a clinically and genetically heterogeneous condition that occurs in isolation (isolated dystonia), in combination with other movement disorders (combined dystonia), or in the context of multisymptomatic phenotypes (isolated or combined dystonia with other neurological involvement). However, our understanding of its aetiology is still incomplete. We aimed to elucidate the monogenic causes for the major clinical categories of dystonia. METHODS: For this exome-wide sequencing study, study participants were identified at 33 movement-disorder and neuropaediatric specialty centres in Austria, Czech Republic, France, Germany, Poland, Slovakia, and Switzerland. Each individual with dystonia was diagnosed in accordance with the dystonia consensus definition. Index cases were eligible for this study if they had no previous genetic diagnosis and no indication of an acquired cause of their illness. The second criterion was not applied to a subset of participants with a working clinical diagnosis of dystonic cerebral palsy. Genomic DNA was extracted from blood of participants and whole-exome sequenced. To find causative variants in known disorder-associated genes, all variants were filtered, and unreported variants were classified according to American College of Medical Genetics and Genomics guidelines. All considered variants were reviewed in expert round-table sessions to validate their clinical significance. Variants that survived filtering and interpretation procedures were defined as diagnostic variants. In the cases that went undiagnosed, candidate dystonia-causing genes were prioritised in a stepwise workflow. FINDINGS: We sequenced the exomes of 764 individuals with dystonia and 346 healthy parents who were recruited between June 1, 2015, and July 31, 2019. We identified causative or probable causative variants in 135 (19%) of 728 families, involving 78 distinct monogenic disorders. We observed a larger proportion of individuals with diagnostic variants in those with dystonia (either isolated or combined) with coexisting non-movement disorder-related neurological symptoms (100 [45%] of 222; excepting cases with evidence of perinatal brain injury) than in those with combined (19 [19%] of 98) or isolated (16 [4%] of 388) dystonia. Across all categories of dystonia, 104 (65%) of the 160 detected variants affected genes which are associated with neurodevelopmental disorders. We found diagnostic variants in 11 genes not previously linked to dystonia, and propose a predictive clinical score that could guide the implementation of exome sequencing in routine diagnostics. In cases without perinatal sentinel events, genomic alterations contributed substantively to the diagnosis of dystonic cerebral palsy. In 15 families, we delineated 12 candidate genes. These include IMPDH2, encoding a key purine biosynthetic enzyme, for which robust evidence existed for its involvement in a neurodevelopmental disorder with dystonia. We identified six variants in IMPDH2, collected from four independent cohorts, that were predicted to be deleterious de-novo variants and expected to result in deregulation of purine metabolism. INTERPRETATION: In this study, we have determined the role of monogenic variants across the range of dystonic disorders, providing guidance for the introduction of personalised care strategies and fostering follow-up pathophysiological explorations. FUNDING: Else Kröner-Fresenius-Stiftung, Technische Universität München, Helmholtz Zentrum München, Medizinische Universität Innsbruck, Charles University in Prague, Czech Ministry of Education, the Slovak Grant and Development Agency, the Slovak Research and Grant Agency.
引用
- Zech M, Jech R, Boesch S, et al. Monogenic variants in dystonia: an exome-wide sequencing study. Lancet Neurol. 2020. PMID: 33098801. doi:10.1016/S1474-4422(20)30312-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。